Pfizer Will Charge Patients $1,390 for COVID Anti-Viral Paxlovid
Pfizer, Inc. plans to charge consumers more than double the price charged to the U.S. government for its COVID-19 anti-viral drug nirmatrelvir-ritonavir, sold under the brand name Paxlovid. A five-day course of the drug to treat COVID will soon cost patients $1,390. According to researchers, it costs Pfizer $13 to manufacture the supply of pills […]
U.S. Taxpayers Fund $5 Billion Project NextGen to Develop Novel COVID Vaccines and Drugs
Just three months after the Biden administration announced that U.S. taxpayers would fund a $5 billion initiative called Project NextGen to develop “next generation” COVID-19 vaccines and therapeutics, the U.S. Department of Health and Human Services’ (HHS) awarded $1.4 billion in contracts under the program on Aug. 22, 2023. The total includes “$1 billion for […]
Paxlovid May Interact With Common Heart Drugs and Cause Blood Clots, Bleeding, Arrhythmia and Muscle Weakness
Findings from a new study published in the Journal of American College of Cardiology found that administration of the anti-viral drug Paxlovid can interact with several commonly prescribed cardiovascular drugs and be associated with an increased risk for blood clots and bleeding, which are termed clinically relevant drug-to-drug interactions (DDI).1 Manufactured by Pfizer, Paxlovid is […]
Pfizer CEO Tests Positive for COVID, Tweets He’s Grateful for Quadruple Vax and Paxlovid Treatment
Albert Bourla is the CEO of Pfizer and just announced on Twitter that he has COVID. He said, “I would like to let you know that I tested positive for COVID-19. I am thankful to have received four doses of the Pfizer-BioNTech vaccine, and I am feeling well while experiencing mild symptoms. I am isolating […]
A Gratitude Script for the COVID Vaccinated But Infected
“I would like to let you know that I have tested positive for #COVID19. I am thankful to have received four doses of the Pfizer-BioNTech vaccine, and I am feeling well while experiencing very mild symptoms. I am isolating and have started a course of Paxlovid.” These were the words of Pfizer CEO Albert Bourla […]
‘COVID-19 Rebound’ May Be Worse Than Initial COVID Illness
On May 24, 2022, the U.S. Centers for Disease Control and Prevention (CDC) issued a health advisory to health care providers, public health departments and the general public regarding Pfizer’s antiviral drug Paxlovid, designed to treat symptoms of COVID-19. The advisory warns that some people who take Paxlovid may experience a recurrence of COVID symptoms […]